May 26, 2006

CORRECTED: FDA approves Merck vaccine to prevent shingles

In BOSTON story headlined "FDA approves Merck vaccine to
prevent shingles," please read in second paragraph ... The
vaccine is designed to prevent shingles ... instead of ... The
vaccine is designed to treat shingles.

A corrected version follows.

BOSTON (Reuters) - Merck & Co. said on Friday that the U.S.
Food and Drug Administration has approved its vaccine to
prevent shingles, a painful disease characterized by a
blistering rash.

The vaccine, Zostavax, is designed to prevent shingles in
individuals over the age of 60. Shingles is caused by the
reactivation of the virus that causes chickenpox.